Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Molecular techniques in hematopathology

A Scarpa1, A Achille

  • 1Department of Pathology, University of Verona, Italy.

Leukemia & Lymphoma
|May 7, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Streptozotocin plus 5-fluorouracil followed by everolimus or the reverse sequence in patients with advanced pancreatic neuroendocrine tumors (SEQTOR-GETNE phase III study): a randomized clinical trial.

ESMO open·2025
Same author

Retraction Note: Angiogenic and signalling proteins correlate with sensitivity to sequential treatment in renal cell cancer.

British journal of cancer·2025
Same author

Long-acting lipegfilgrastim and antimicrobials as vigorous primary prophylaxis in bendamustine-treated patients with indolent B cell non-Hodgkin lymphoma: a multicentric real-life experience.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2025
Same author

Artificial intelligence entering the pathology arena in oncology: current applications and future perspectives.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Bendamustine supercharge plus brentuximab vedotin as early salvage therapy following failure to obtain complete metabolic remission after two cycles of adriamycin-bleomycin-vinblastine-dacarbazine for classic Hodgkin lymphoma in patients aged ≤ 60 years: Long-term efficacy results of a retrospective multicentre study.

British journal of haematology·2025
Same author

Corrigendum to "Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group": [Ann Oncol 35 (2024) 588-606].

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same journal

CPX‑351 vs. FLAG‑ida in patients with high-risk AML/MDS and MDS-related gene mutations: a subgroup analysis of the UK NCRI AML19 trial.

Leukemia & lymphoma·2026
Same journal

Specialist palliative care access and end-of-life hospitalizations in acute leukemia: a nationwide register study.

Leukemia & lymphoma·2026
Same journal

D-VRD vs. D-KRD induction in transplant-eligible multiple myeloma: a real-world comparison.

Leukemia & lymphoma·2026
Same journal

T-box factor EOMES is part of an aberrant network in Hodgkin lymphoma.

Leukemia & lymphoma·2026
Same journal

Overall survival of patients with chronic lymphocytic leukemia treated with venetoclax-obinutuzumab compared to age- and sex-matched general population.

Leukemia & lymphoma·2026
Same journal

Hypertension and time to treatment failure with acalabrutinib and ibrutinib in treatment-naïve CLL/SLL.

Leukemia & lymphoma·2026
See all related articles

Molecular genetic techniques, including DNA analysis via Southern blotting and polymerase chain reaction (PCR), are crucial for diagnosing, predicting, and monitoring hematologic cancers. These methods detect DNA rearrangements and gene alterations, aiding clinical decisions.

Area of Science:

  • Hematology
  • Molecular Pathology
  • Oncology

Background:

  • Clinical hematologists require molecular insights for accurate diagnosis, prognosis, and therapeutic strategies in hematologic disorders.
  • Pathology practices are integrating advanced molecular genetic techniques alongside traditional methods like morphology and immunocytochemistry.
  • DNA-based molecular methods are becoming standard for comprehensive patient management.

Purpose of the Study:

  • To provide an overview of molecular genetic techniques in pathology practice.
  • To highlight the role of these techniques in diagnosing and managing neoplastic hematologic diseases.
  • To illustrate the application of molecular methods using practical examples.

Main Methods:

  • Focus on DNA analysis methodologies, including Southern blotting and polymerase chain reaction (PCR).

Related Experiment Videos

  • Southern blotting is used for detecting major DNA rearrangements.
  • PCR techniques are employed for identifying chromosomal modifications and gene alterations, including point mutations, even in degraded DNA samples.

    • Main Results:

    • Molecular techniques offer valuable information beyond traditional diagnostic methods.
    • PCR is versatile, detecting both large-scale and small-scale genetic changes.
    • These methods are applicable to various sample types, including formalin-fixed paraffin-embedded tissues.

    Conclusions:

    • Molecular genetic techniques are indispensable tools in modern hematologic pathology.
    • The integration of DNA analysis enhances diagnostic accuracy, prognostic prediction, and patient follow-up.
    • Continued application of these techniques is vital for advancing the care of patients with hematologic malignancies.